01 January 2018 3 4K Report

Are gene mutation (BRAF, KRAS, PTEN, and TP53) analyses required to define type 1 and type 2 ovarian cancers? Or, cell morphology is enough to define ovarian cancer types. Thanks.

Similar questions and discussions